Industry leaders interested in advancing the mission of HealthyWomen, and educating millions of women about the health issues that concern them, the most are members of our Corporate Advisory Board.
AANP
Amgen
Astellas
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members develop innovative products to improve the world's health, climate and nutrition. For more information visit bio.org, Twitter, Facebook, LinkedIn, and YouTube.
Bristol Myers Squibb
Edwards Lifesciences
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter and LinkedIn.
Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future.
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies in glaucoma, corneal health and retinal disease.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women throughout the world.
At Horizon, we believe science and compassion must work together to transform lives. Our mission to deliver medicines for rare, autoimmune and severe inflammatory diseases and provide compassionate support comes from our strong and simple philosophy to make a meaningful difference for patients and communities in need.
Idorsia is reaching out for more – we have more ideas, we see more opportunities, and we want to help more patients. To achieve this, we will utilize our strong scientific core to bring innovative medicines from bench to bedside with the potential to change the lives of many patients.
Invivyd is an antibody-based viral infectious disease company on a mission to transcend the limitations of the human immune system. The company is developing engineered antibodies to provide durable protection from viral infectious diseases, beginning with COVID-19.
Novartis is reimagining medicine to improve and extend people's lives. We deliver high-value medicines that alleviate society's greatest disease burdens through technology leadership in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development.
Novavax
Novo Nordisk
Organon is a global women’s health pharmaceutical company with a vision to create a better and healthier every day for every woman. We are fearless in our goal to deliver innovation, improve access, and expand choice to help address critical therapeutic area gaps and ultimately improve the lives of women and their communities around the world. That commitment has helped us broaden our focus across multiple areas affecting women's health. And we will continue to invest in high-need areas that have no established precedent.
Pfizer
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. Since 2000, PhRMA member companies have invested more than $1.1 trillion in the search for new treatments and cures, including $102.3 billion in 2021 alone.
Pioneering access for patients.
Sumitomo Pharma America (SMPA) is deeply committed to accelerating scientific and therapeutic breakthroughs to support patient-first outcomes in areas of critical need, including psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies.
Viatris empowers people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to improve patient health.